Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Improving IHC reference standards
October 2016
SHARING OPTIONS:

CAMBRIDGE, U.K.—Horizon Discovery Group plc and Ventana Medical Systems Inc., a member of the Roche Group, joined forces in a co-development and commercialization agreement in early September. The agreement will cover the development, manufacture and commercialization of cell line derivative materials for use as immunohistochemistry (IHC) reference standards in cancer tissue diagnostics to support development and validation of IHC assays. Per the agreement, Ventana has an option to commission projects from Horizon, with Horizon developing applicable cell lines and associated derivative reference standard materials. Horizon will be primarily responsible for commercializing the reference standards and will serve as primary distribution channel. Ventana will have the option to co-distribute any developed reference standards.
 
Paul Morrill, president of products at Horizon, stated that “We are excited to continue to strengthen our relationship with Ventana, developing reference standards in areas of significant need and exploring the opportunity for follow-on OEM agreements.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.